Literature DB >> 18234764

More on HIV-associated Kaposi's sarcoma.

Susan E Krown, Jeannette Y Lee, Dirk P Dittmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18234764      PMCID： PMC2857919          DOI： 10.1056/NEJMc072994

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.

Authors:  Toby Maurer; Maya Ponte; Kieron Leslie
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

2.  Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.

Authors:  V Martinez; E Caumes; L Gambotti; H Ittah; J-P Morini; J Deleuze; I Gorin; C Katlama; F Bricaire; N Dupin
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640
  2 in total
  52 in total

1.  Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

Authors:  Zhiqiang Qin; Michael DeFee; Jennifer S Isaacs; Chris Parsons
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

2.  Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study.

Authors:  Susan E Krown; Debasmita Roy; Jeannette Y Lee; Bruce J Dezube; Erin G Reid; Raman Venkataramanan; Kelong Han; Ethel Cesarman; Dirk P Dittmer
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

Review 3.  HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.

Authors:  Ryan J Sullivan; Liron Pantanowitz; Corey Casper; Justin Stebbing; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

Review 4.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

5.  Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.

Authors:  Dirk P Dittmer; Kristen Tamburro; Huichao Chen; Anthony Lee; Marcia K Sanders; Tischan A Wade; Sonia Napravnik; Jennifer Webster-Cyriaque; Mahmoud Ghannoum; Caroline H Shiboski; Judith A Aberg
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 6.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

7.  Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.

Authors:  Zhiqiang Qin; Eduardo Freitas; Roger Sullivan; Sarumathi Mohan; Rocky Bacelieri; Drake Branch; Margaret Romano; Patricia Kearney; Jim Oates; Karlie Plaisance; Rolf Renne; Johnan Kaleeba; Chris Parsons
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

8.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

9.  Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.

Authors:  Sara Lodi; Marguerite Guiguet; Dominique Costagliola; Martin Fisher; Andrea de Luca; Kholoud Porter
Journal:  J Natl Cancer Inst       Date:  2010-05-04       Impact factor: 13.506

10.  Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.

Authors:  Andrea J O'Hara; Pauline Chugh; Ling Wang; Eduardo M Netto; Estrella Luz; William J Harrington; Bruce J Dezube; Blossom Damania; Dirk P Dittmer
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.